Yokoyama, Keitaro http://orcid.org/0000-0002-6122-592X
Hashimoto, Teruo
Okuda, Yuri
Matsumoto, Yu
Ito, Kyoko
Yamada, Ryoichi
Susai, Hiroyuki
Nishino, Noriaki
Funding for this research was provided by:
Japan Tobacco Inc.
Torii Pharmaceutical Co., Ltd.
Article History
Received: 8 November 2021
Accepted: 19 February 2022
First Online: 8 March 2022
Declarations
:
: Keitaro Yokoyama has received honoraria from Japan Tobacco Inc., Torii Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., and Kyowa Kirin Co., Ltd. Teruo Hashimoto, Yuri Okuda, Yu Matsumoto, Ryoichi Yamada, and Hiroyuki Susai are employees of Japan Tobacco Inc. Kyoko Ito and Noriaki Nishino are employees of Torii Pharmaceutical Co., Ltd. This surveillance study was funded by Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd.
: This was an observational post-marketing surveillance study and was conducted in accordance with the Good Post-Marketing Study Practice (GPSP) of the Ministry of Health, Labour and Welfare in Japan. The requirement for informed consent was waived because the intervention was within general clinical practice and the data were anonymized.